期刊文献+

心房颤动及复律药物的研究新进展 被引量:4

New progress on the research of atrial fibrillation and cardioversion drugs
下载PDF
导出
摘要 心房颤动(atrial fibrillation,AF)是一种心房快速紊乱的心律失常,是一种以心房不协调活动而导致心房机械功能恶化为特征的室上性心律失常,也是目前临床上最常见及危害最严重的心律失常之一,可引起血流动力学发生改变和脑栓塞等严重并发症,因此,房颤已成为心律失常领域的研究热点.世界范围内有3%~5%的人群发生房颤。普通人群发病率为0.7%~1.0%,65岁以上人群发病率约5%,80岁以上老年人发病率高达8%~9%。
出处 《中国心血管病研究》 CAS 2014年第8期739-743,共5页 Chinese Journal of Cardiovascular Research
基金 黑龙江省卫生厅项目(项目编号:2010-287)
关键词 心房颤动 心脏复律 药物 伊布利特 Atrial fibrillation Cardioversion Drugs Ibutilide
  • 相关文献

参考文献22

  • 1Fioranelli M,Piccoli M,Mileto GM,et al.Modifications incardiovasular functional parameters with aging.Minerva Cardioangiol,2001,39:169-178.
  • 2李妙龄,曾晓荣,杨艳,刘智飞,周文,丁银元,裴杰.持续性心房颤动患者心房肌细胞L型钙通道电流变化的研究[J].中华心血管病杂志,2006,34(4):308-311. 被引量:17
  • 3Gollob MH.Cardiac connexins as candidate genes for idiopathic atrial fibrillation.Current Opinion in Cardiology,2006,21:155-158.
  • 4Boos CJ,Anderson RA,Lip GY.Is atrial fibrillation an inflammatory disorder? Eur Heart J,2006,27:136-149.
  • 5Corradi D,Callegari S,Maestri R,et al.Structural remodeling in atrial fibrillation.Nat Clin Pract Cardiovasc Med,2008,5:782-796.
  • 6Tsioufis C,Syrseloudis D,Hatziyianni A,et al.Relationships of CRP and P wave dispersion with atrial fibrillation in hypertensive subjects.Am J Hypertens,2010,23:202-207.
  • 7Chen YH,Xu SJ,Bendehhou S,et al.KCNQI gain-of-function mutation in familial atrial fibrillation.Science,2003,299:251-254.
  • 8Oberti C,Wang L,Li L,et al.Genome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy.Circulation,2004,110:3753-3759.
  • 9C ai X,Zhang Z,Liang Y,et al.MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease.Clinica Chimica Acta,2010,411:719.
  • 10马长生.2012年欧洲心脏病学会心房颤动治疗指南更新解读[J].中国循环杂志,2012,27(S01):6-11. 被引量:12

二级参考文献41

  • 1马长生,汤日波.心房颤动导管消融进展[J].中国心血管病研究,2007,5(4):241-243. 被引量:6
  • 2裴德安,李莉,徐志云,邹良建,张宝仁,黄盛东,郝家骅,王志农.心房颤动患者心房组织醛固酮水平与心房结构重构的相关性研究[J].第二军医大学学报,2007,28(2):170-174. 被引量:9
  • 3[1]Stanton A, Jensen C, Nussberger J. Blood pressure lowering in essential hypertension with an oral renin inhibitor,aliskiren. Hypertension. 2003, 42(6):1137-1143.
  • 4[2]Jafar TH, Schmid CH, Levey AS. Effect of angiotensinconverting enzyme inhibitors on progression of nondiabetic renal disease. Ann Intern Med. 2002, 137(4):298-299.
  • 5[3]Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.Lancet, 2002, 359(9311):1004-1010.
  • 6[4]Jay N, Cohn MD, Gianni T. A randomized trial of the angiotensin-receptor blocker valsartan chronic heart failure.N Engl J Med, 2001, 345(23): 1667-1675A.
  • 7[5]Scott DS, Duolao W, Peter F, et al. Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients.Circulation, 2004,110:2180-2183.
  • 8[6]Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 2004, 363(9426):2022-2031.
  • 9[7]David A, Scott DS, Lars K, et al. Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction. The Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Circulation, 2004,110:1572-1578.
  • 10[8]Brenner BM, Cooper ME, Keane WF, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med,2001, 345(12):861-891.

共引文献44

同被引文献40

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部